歌礼制药发布公告，宣布上海市公共卫生临床中心在澳大利亚布里斯班及线上举行的第12届国际艾滋病协会HIV科学会议上公布ASC22(恩沃利单抗)联合西达本胺用于人类免疫缺陷病毒(HIV)感染功能性治癒的临床结果。
公告指，这项研究者发起的II期试验(ClinicalTrials.gov：NCT05129189)由上海市公共卫生临床中心感染与免疫科副主任医师陈军博士领导，共入组了15名已实现病毒学抑制的HIV感染者。该研究旨在评估ASC22(恩沃利单抗)联合西达本胺在HIV感染者中对被感染的潜伏期细胞病毒储存库的疗效。歌礼生物科技(杭州)有限公司(本公司的全资附属公司)提供本次临床试验的ASC22(恩沃利单抗)。
此项II期临床试验显示ASC22联合西达本胺疗法具有良好的耐受性，且有效地激活了潜伏的HIV病毒库。
来源：港交所
正文完
可以使用微信扫码关注公众号（ID：xzluomor）
ufabet
มีเกมให้เลือกเล่นมากมาย: เกมเดิมพันหลากหลาย ครบทุกค่ายดัง
tornado crypto mixer
Discover the power of privacy with TornadoCash! Learn how this decentralized mixer ensures your transactions remain confidential.
ดูบอลสด
Very well presented. Every quote was awesome and thanks for sharing the content. Keep sharing and keep motivating others.
ดูบอลสด
Pretty! This has been a really wonderful post. Many thanks for providing these details.
ดูบอลสด
Pretty! This has been a really wonderful post. Many thanks for providing these details.
ดูบอลสด
Hi there to all, for the reason that I am genuinely keen of reading this website’s post to be updated on a regular basis. It carries pleasant stuff.
Obrazy Sztuka Nowoczesna
Thank you for this wonderful contribution to the topic. Your ability to explain complex ideas simply is admirable.
ufabet
Hi there to all, for the reason that I am genuinely keen of reading this website’s post to be updated on a regular basis. It carries pleasant stuff.
ufabet
Very well presented. Every quote was awesome and thanks for sharing the content. Keep sharing and keep motivating others.
